Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General15 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General10 hours agoInternal Revenue Service starts cutting 20,000 workers